Trials / Completed
CompletedNCT06373744
Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 597 (actual)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to learn about the effects of metronomic chemotherapy in advanced breast cancer patients. The main question it aims to answer is: How effective is metronomic chemotherapy in advanced breast cancer? Specific benefit groups of metronomic chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | cyclophosphamide , methotrexate , vinorelbine ,capecitabine | The drugs used in metronomic chemotherapy are cyclophosphamide (CTX), methotrexate (M), vinorelbine (VNR), and capecitabine |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2024-01-01
- Completion
- 2024-01-01
- First posted
- 2024-04-18
- Last updated
- 2024-04-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06373744. Inclusion in this directory is not an endorsement.